Alessandro Granito et al. described that Tregs, with CD4+ CD25+ Foxp3+ as molecular markers, had a suppressive effect on CD8+ T cells and NK cells in the development of HCC, thus reducing the effect of the host immune system on tumor cell death [28]. The gene discussed is CD8A; the disease is neoplasm.